BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16554152)

  • 21. 4-Hydroxy-5-pyrrolinone-3-carboxamide HIV-1 integrase inhibitors.
    Pace P; Spieser SA; Summa V
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3865-9. PubMed ID: 18595690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 5,6,7,8-Tetrahydro-1,6-naphthyridine Derivatives as Potent HIV-1-Integrase-Allosteric-Site Inhibitors.
    Peese KM; Allard CW; Connolly T; Johnson BL; Li C; Patel M; Sorensen ME; Walker MA; Meanwell NA; McAuliffe B; Minassian B; Krystal M; Parker DD; Lewis HA; Kish K; Zhang P; Nolte RT; Simmermacher J; Jenkins S; Cianci C; Naidu BN
    J Med Chem; 2019 Feb; 62(3):1348-1361. PubMed ID: 30609350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of 2-t butyl-N-methyl pyrimidones as potent inhibitors of HIV integrase.
    Di Francesco ME; Pace P; Fiore F; Naimo F; Bonelli F; Rowley M; Summa V
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2709-13. PubMed ID: 18362069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
    Lee SU; Shin CG; Lee CK; Lee YS
    Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naphthoxazepine inhibitors of HIV-1 integrase: synthesis and biological evaluation.
    Garofalo A; Grande F; Brizzi A; Aiello F; Dayam R; Neamati N
    ChemMedChem; 2008 Jun; 3(6):986-90. PubMed ID: 18383063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformationally restrained carbazolone-containing alpha,gamma-diketo acids as inhibitors of HIV integrase.
    Li X; Vince R
    Bioorg Med Chem; 2006 May; 14(9):2942-55. PubMed ID: 16386908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 6-Benzylamino 4-oxo-1,4-dihydro-1,8-naphthyridines and 4-oxo-1,4-dihydroquinolines as HIV integrase inhibitors.
    Nagasawa JY; Song J; Chen H; Kim HW; Blazel J; Ouk S; Groschel B; Borges V; Ong V; Yeh LT; Girardet JL; Vernier JM; Raney AK; Pinkerton AB
    Bioorg Med Chem Lett; 2011 Jan; 21(2):760-3. PubMed ID: 21185178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1.
    Zhao XZ; Smith SJ; Métifiot M; Marchand C; Boyer PL; Pommier Y; Hughes SH; Burke TR
    J Med Chem; 2014 Jun; 57(12):5190-202. PubMed ID: 24901667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A platform for designing HIV integrase inhibitors. Part 1: 2-hydroxy-3-heteroaryl acrylic acid derivatives as novel HIV integrase inhibitor and modeling of hydrophilic and hydrophobic pharmacophores.
    Kawasuji T; Yoshinaga T; Sato A; Yodo M; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8430-45. PubMed ID: 17010623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-(4-Fluorobenzyl)-3-hydroxy-9,9-dimethyl-4-oxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a]pyrimidine-2-carboxamides a novel class of potent HIV-1 integrase inhibitors.
    Petrocchi A; Jones P; Rowley M; Fiore F; Summa V
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4245-9. PubMed ID: 19523819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery and structure-activity relationship studies of a unique class of HIV-1 integrase inhibitors.
    Dayam R; Sanchez T; Neamati N
    ChemMedChem; 2006 Feb; 1(2):238-44. PubMed ID: 16892356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 8-Hydroxy-3,4-dihydropyrrolo[1,2-a]pyrazine-1(2H)-one HIV-1 integrase inhibitors.
    Fisher TE; Kim B; Staas DD; Lyle TA; Young SD; Vacca JP; Zrada MM; Hazuda DJ; Felock PJ; Schleif WA; Gabryelski LJ; Anari MR; Kochansky CJ; Wai JS
    Bioorg Med Chem Lett; 2007 Dec; 17(23):6511-5. PubMed ID: 17931865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 4,5-dihydroxypyrimidine carboxamides and N-alkyl-5-hydroxypyrimidinone carboxamides are potent, selective HIV integrase inhibitors with good pharmacokinetic profiles in preclinical species.
    Summa V; Petrocchi A; Matassa VG; Gardelli C; Muraglia E; Rowley M; Paz OG; Laufer R; Monteagudo E; Pace P
    J Med Chem; 2006 Nov; 49(23):6646-9. PubMed ID: 17154493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rationally designed dual inhibitors of HIV reverse transcriptase and integrase.
    Wang Z; Bennett EM; Wilson DJ; Salomon C; Vince R
    J Med Chem; 2007 Jul; 50(15):3416-9. PubMed ID: 17608468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors.
    Kawasuji T; Fuji M; Yoshinaga T; Sato A; Fujiwara T; Kiyama R
    Bioorg Med Chem; 2006 Dec; 14(24):8420-9. PubMed ID: 17005407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
    De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
    Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newer tetracycline derivatives: synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase.
    Sriram D; Yogeeswari P; Senchani G; Banerjee D
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2372-5. PubMed ID: 17376679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and HIV-integrase strand transfer inhibition activity of 7-hydroxy[1,3]thiazolo[5,4-b]pyridin-5(4H)-ones.
    Boros EE; Johns BA; Garvey EP; Koble CS; Miller WH
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5668-72. PubMed ID: 16908139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
    Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations on the 4-quinolone-3-carboxylic acid motif. 1. Synthesis and structure-activity relationship of a class of human immunodeficiency virus type 1 integrase inhibitors.
    Pasquini S; Mugnaini C; Tintori C; Botta M; Trejos A; Arvela RK; Larhed M; Witvrouw M; Michiels M; Christ F; Debyser Z; Corelli F
    J Med Chem; 2008 Aug; 51(16):5125-9. PubMed ID: 18665580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.